Volume | 328,831 |
|
|||||
News | - | ||||||
Day High | 0.6199 | Low High |
|||||
Day Low | 0.5736 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ZyVersa Therapeutics Inc | ZVSA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.599 | 0.5736 | 0.6199 | 0.61 | 0.5627 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
14,935 | 328,831 | $ 0.5952013 | $ 195,721 | - | 0.50 - 90.65 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:58:54 | 1 | $ 0.5975 | USD |
ZyVersa Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
27.97M | 1.24M | - | 0 | -106.25M | -85.46 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ZyVersa Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZVSA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.5984 | 0.642 | 0.55 | 0.5935046 | 268,320 | 0.0106 | 1.77% |
1 Month | 0.75 | 0.84 | 0.55 | 0.6958233 | 343,219 | -0.141 | -18.80% |
3 Months | 0.59 | 2.50 | 0.54 | 0.9942749 | 2,640,056 | 0.019 | 3.22% |
6 Months | 4.165 | 4.375 | 0.50 | 1.88 | 2,900,364 | -3.56 | -85.38% |
1 Year | 75.60 | 90.65 | 0.50 | 5.71 | 3,477,182 | -74.99 | -99.19% |
3 Years | 490.00 | 523.25 | 0.50 | 8.89 | 2,651,737 | -489.39 | -99.88% |
5 Years | 490.00 | 523.25 | 0.50 | 8.89 | 2,651,737 | -489.39 | -99.88% |
ZyVersa Therapeutics Description
ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases. |